asa glp 1 agonist guidelines 🔸 Should GLP-1 RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f ASA Advises No Longer Holding

Higher pricing does not automatically indicate better quality, but it often correlates with clearer testing disclosure, better documentation, and more consistent presentation

As a secondary analysis, the authors performed safety assessments including incidence, severity, and relatedness to the treatment of AEs

Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2

Others are modified versions, as with many of the blockbuster GLP-1 weight loss drugs

Silver nanoparticles functionalized with antimicrobial polypeptides: benefits and possible pitfalls of a novel anti-infective tool